New antimicrobial agents for the treatment of Gram-positive bacterial infections

D Y Aksoy1, S Unal

  • 1Department of Internal Medicine, Medical Faculty, Hacettepe Univrsity, Ankara, Turkey. duyguyaks@yahoo.com

Insights

Antimicrobial resistance is a growing global health threat, especially for Gram-positive bacterial infections. New drugs like linezolid and daptomycin offer hope for treating resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance has escalated since the 1970s, complicating treatment of Gram-positive bacterial infections.
  • Multidrug-resistant organisms such as MRSA, resistant pneumococci, and VRE pose significant clinical challenges.
  • The pharmaceutical industry is actively developing novel antimicrobial agents to combat these resistant infections.

Purpose of the Study:

  • To review recently introduced and clinically developing antimicrobial agents.
  • To summarize the properties and recent study results of these new agents.
  • To discuss future treatment possibilities for resistant infections.

Main Methods:

  • Literature review of recent studies on new antimicrobial agents.
  • Analysis of properties and clinical data for agents like linezolid, quinupristin-dalfopristin, daptomycin, tigecycline, new glycopeptides, and ceftobiprole.

Main Results:

  • Several new agents including linezolid, quinupristin-dalfopristin, daptomycin, tigecycline, new glycopeptides, and ceftobiprole are available or in development.
  • These agents exhibit diverse mechanisms of action and spectrums of activity against resistant Gram-positive pathogens.
  • Recent studies demonstrate varying efficacy and safety profiles for these novel therapeutics.

Conclusions:

  • New antimicrobial agents are crucial for managing infections caused by multidrug-resistant Gram-positive bacteria.
  • Continued research and development are essential to address the evolving challenge of antimicrobial resistance.
  • These emerging therapies hold promise for improving treatment outcomes in the future.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...